Steris reported $1.27B in Operating Expenses for its fiscal quarter ending in September of 2026.





Operating Expenses Change Date
3M USD 5.03B 141M Sep/2026
Accuray USD 37.18M 567K Dec/2024
Baxter International USD 6.5B 3.82B Sep/2026
Becton, Dickinson and Co. USD 4.16B 20.25B Sep/2026
Boston Scientific USD 4.13B 72M Sep/2026
CONMED USD 298.41M 8.67M Sep/2026
Cooper Companies USD 844.2M 268.3M Jun/2026
Dexcom USD 990.1M 53.5M Jun/2026
Ecolab USD 3.8B 196.5M Sep/2026
Edwards Lifesciences USD 10.86B 9.64B Sep/2026
Fortive USD 871.6M 15.3M Sep/2026
Getinge SEK 7.03B 2.96B Jun/2026
Globus Medical USD 585.49M 250.09M Sep/2026
Haemonetics USD 145.79M 448K Sep/2026
Idexx Laboratories USD 811.89M 20.87M Sep/2026
Inogen USD 49.14M 665K Sep/2024
Insulet USD 652.2M 19.8M Sep/2026
Integra LifeSciences USD 368.53M 674.84M Sep/2026
Intuitive Surgical USD 2B 86.5M Sep/2026
J&J USD 18.93B 1.09B Sep/2026
Olympus JPY 213.3B 2.97B Sep/2026
Orthofix International USD 213.79M 12.36M Dec/2025
Owens Minor USD -568.23M 17.29M Sep/2026
ResMed USD 1.01B 83.57M Jun/2026
Steris USD 1.27B 62.5M Sep/2026
Stryker USD 4.8B 118M Jun/2026
Tandem Diabetes Care USD 286.06M 17.71M Sep/2026
Teleflex USD 3.49B 589.18M Sep/2026
Thermo Fisher Scientific USD 9.68B 134M Sep/2026
Zimmer Biomet Holdings USD 1.72B 110.9M Sep/2026